Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Clump

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 16, 2019
Impact of Neck Disability on Health-Related Quality of Life among Head and Neck Cancer SurvivorsMarci L Nilsen, Lingyun Lyu, Michael A Belsky, et al.
Oral Oncology|August 18, 2016
Association of pretreatment body mass index and survival in human papillomavirus positive oropharyngeal squamous cell carcinomaWilliam G Albergotti, Kara S Davis, Shira Abberbock, et al.
JCI Insight|February 22, 2023
The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapyFrank P Vendetti, Pinakin Pandya, David A Clump, et al.
Head & Neck|May 19, 2020
Prevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemicMarci Lee Nilsen, David A Clump, Mark Kubik, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2013
Target delineation in stereotactic body radiation therapy for recurrent head and neck cancer: a retrospective analysis of the impact of margins and automated PET-CT segmentationKyle Wang, Dwight E Heron, David A Clump, et al.
Cancer|October 7, 2018
Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlativesJulie E Bauman, Umamaheswar Duvvuri, Sufi Thomas, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2015
A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neckJohn A Vargo, Robert L Ferris, James Ohr, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2021
Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck RetreatmentsJimm Grimm, John A Vargo, Panayiotis Mavroidis, et al.
Radiation Oncology (London, England)|February 1, 2014
Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapyZachary D Horne, David A Clump, John A Vargo, et al.
International Journal of Radiation Oncology, Biology, Physics|February 26, 2018
Head and Neck Tumor Control Probability: Radiation Dose-Volume Effects in Stereotactic Body Radiation Therapy for Locally Recurrent Previously-Irradiated Head and Neck Cancer: Report of the AAPM Working GroupJohn A Vargo, Vitali Moiseenko, Jimm Grimm, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 16, 2019
Impact of Neck Disability on Health-Related Quality of Life among Head and Neck Cancer SurvivorsMarci L Nilsen, Lingyun Lyu, Michael A Belsky, et al.
Oral Oncology|August 18, 2016
Association of pretreatment body mass index and survival in human papillomavirus positive oropharyngeal squamous cell carcinomaWilliam G Albergotti, Kara S Davis, Shira Abberbock, et al.
JCI Insight|February 22, 2023
The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapyFrank P Vendetti, Pinakin Pandya, David A Clump, et al.
Head & Neck|May 19, 2020
Prevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemicMarci Lee Nilsen, David A Clump, Mark Kubik, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2013
Target delineation in stereotactic body radiation therapy for recurrent head and neck cancer: a retrospective analysis of the impact of margins and automated PET-CT segmentationKyle Wang, Dwight E Heron, David A Clump, et al.
Cancer|October 7, 2018
Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlativesJulie E Bauman, Umamaheswar Duvvuri, Sufi Thomas, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2015
A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neckJohn A Vargo, Robert L Ferris, James Ohr, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2021
Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck RetreatmentsJimm Grimm, John A Vargo, Panayiotis Mavroidis, et al.
Radiation Oncology (London, England)|February 1, 2014
Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapyZachary D Horne, David A Clump, John A Vargo, et al.
International Journal of Radiation Oncology, Biology, Physics|February 26, 2018
Head and Neck Tumor Control Probability: Radiation Dose-Volume Effects in Stereotactic Body Radiation Therapy for Locally Recurrent Previously-Irradiated Head and Neck Cancer: Report of the AAPM Working GroupJohn A Vargo, Vitali Moiseenko, Jimm Grimm, et al.
Pageof 8